PATENT CLAIM ANALYSIS

Application Number: 15871802
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["424", "131100"]

Abstract:
Provided are anti-CD47 monoclonal antibodies (anti-CD47 mAbs) with distinct functional profiles as described herein, methods to generate anti-CD47 mAbs, and to methods of using these anti-CD47 mAbs as therapeutics for the prevention and treatment of solid and hematological cancers, ischemia-reperfusion injury, cardiovascular diseases, autoimmune diseases, inflammatory diseases or as diagnostics for determining the level of CD47 in tissue samples.

Claim (Index 114):
A method of treating a disease comprising an autoimmune disease, an autoinflammatory disease, an inflammatory disease, a cardiovascular disease, or a cancer in a subject, comprising administration of the monoclonal antibody or antigen-binding fragment thereof, of  claim 109 , wherein subject comprises a human or companion/pet animal, a working animal, a sport animal, a zoo animal, or a valuable animal kept in captivity.

Metadata:
- Claim Count in Document: 119.0
- Percentile: 86.0
- Lexical Diversity: 1.47826
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15820054', '15711971', '15473206', '15712010', '14700105']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7498382028627385
- 35 USC 102 Novelty (BERT): 0.6265663731775696
- Combined Prediction Score: 0.7375110198942216
- Mean Citation Score: 516.6316039999998
- Max Citation Score: 732.64636
- Similarity Product: 495.520996856761

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test